Tema Oncology ETF
Registrant
Tema ETF Trust
Class ticker
Net Assets
$176,140,765
Holdings
50
Latest Report
May 31, 2026
Net Assets Over Time
Holdings · 50
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$176,140,765 in net assets.
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | RVMD | 86,450 | $13,614,146 | 7.73% | Long | EC | |
| Eli Lilly & Co | LLY | 7,684 | $8,490,820 | 4.82% | Long | EC | |
| Cogent Biosciences Inc | COGT | 206,419 | $7,216,408 | 4.10% | Long | EC | |
| Immunome Inc | IMNM | 315,648 | $6,890,596 | 3.91% | Long | EC | |
| Celcuity Inc | CELC | 47,450 | $6,305,156 | 3.58% | Long | EC | |
| Merck & Co Inc | MRK | 52,978 | $6,289,548 | 3.57% | Long | EC | |
|
Nuvalent Inc
|
670703107 | 53,763 | $5,934,898 | 3.37% | Long | EC | |
| Bristol-Myers Squibb Co | BMY | 101,680 | $5,814,062 | 3.30% | Long | EC | |
| Legend Biotech Corp | LEGN | 194,092 | $5,271,539 | 2.99% | Long | EC | |
| AbbVie Inc | ABBV | 22,700 | $4,942,244 | 2.81% | Long | EC | |
| Exelixis Inc | EXEL | 96,885 | $4,890,755 | 2.78% | Long | EC | |
| Bridgebio Pharma Inc | BBIO | 73,191 | $4,849,636 | 2.75% | Long | EC | |
| Johnson & Johnson | JNJ | 19,900 | $4,484,067 | 2.55% | Long | EC | |
| CG oncology Inc | CGON | 68,702 | $4,279,448 | 2.43% | Long | EC | |
| Genmab A/S | GMAB | 158,861 | $4,182,810 | 2.37% | Long | EC | |
| Ideaya Biosciences Inc | IDYA | 135,847 | $4,003,411 | 2.27% | Long | EC | |
| Amgen Inc | AMGN | 11,019 | $3,711,089 | 2.11% | Long | EC | |
| Zai Lab Ltd | ZLAB | 196,972 | $3,484,435 | 1.98% | Long | EC | |
| BeOne Medicines Ltd | ONC | 11,505 | $3,312,520 | 1.88% | Long | EC | |
| Zymeworks Inc | ZYME | 105,615 | $2,654,105 | 1.51% | Long | EC | |
| Enliven Therapeutics Inc | ELVN | 58,197 | $2,302,855 | 1.31% | Long | EC | |
| Relay Therapeutics Inc | RLAY | 161,076 | $2,263,118 | 1.28% | Long | EC | |
| Halozyme Therapeutics Inc | HALO | 32,598 | $2,169,071 | 1.23% | Long | EC | |
| Summit Therapeutics Inc | SMMT | 121,097 | $2,124,041 | 1.21% | Long | EC | |
| Arcus Biosciences Inc | RCUS | 83,140 | $2,106,768 | 1.20% | Long | EC | |
| Gilead Sciences Inc | GILD | 14,692 | $1,975,046 | 1.12% | Long | EC | |
| Erasca Inc | ERAS | 147,828 | $1,898,112 | 1.08% | Long | EC | |
| Nuvation Bio Inc | NUVB | 395,313 | $1,889,596 | 1.07% | Long | EC | |
| AnaptysBio Inc | ANAB | 31,270 | $1,740,801 | 0.99% | Long | EC | |
| Guardant Health Inc | GH | 10,986 | $1,424,774 | 0.81% | Long | EC | |
| Syndax Pharmaceuticals Inc | SNDX | 72,212 | $1,414,633 | 0.80% | Long | EC | |
| Corvus Pharmaceuticals Inc | CRVS | 108,477 | $1,346,200 | 0.76% | Long | EC | |
| Regeneron Pharmaceuticals Inc | REGN | 2,138 | $1,314,400 | 0.75% | Long | EC | |
| ArriVent Biopharma Inc | AVBP | 42,744 | $1,293,861 | 0.73% | Long | EC | |
| Iovance Biotherapeutics Inc | IOVA | 280,048 | $1,148,197 | 0.65% | Long | EC | |
| Inhibrx Biosciences Inc | INBX | 10,170 | $1,057,782 | 0.60% | Long | EC | |
| Olema Pharmaceuticals Inc | OLMA | 79,759 | $1,052,021 | 0.60% | Long | EC | |
| Cullinan Therapeutics Inc | CGEM | 62,826 | $1,032,859 | 0.59% | Long | EC | |
| Natera Inc | NTRA | 4,238 | $946,642 | 0.54% | Long | EC | |
| First Tracks Biotherapeutics I | TRAX | 58,419 | $932,367 | 0.53% | Long | EC | |
| Immunocore Holdings PLC | IMCR | 30,849 | $891,228 | 0.51% | Long | EC | |
| BridgeBio Oncology Therapeutic | BBOT | 93,339 | $837,251 | 0.48% | Long | EC | |
| CytomX Therapeutics Inc | CTMX | 228,987 | $824,353 | 0.47% | Long | EC | |
| HUTCHMED China Ltd | HCM | 67,823 | $776,573 | 0.44% | Long | EC | |
| Arvinas Inc | ARVN | 84,124 | $755,434 | 0.43% | Long | EC | |
| Janux Therapeutics Inc | JANX | 51,522 | $751,706 | 0.43% | Long | EC | |
| Adlai Nortye Ltd | ANL | 44,354 | $529,587 | 0.30% | Long | EC | |
| Tyra Biosciences Inc | TYRA | 15,780 | $527,210 | 0.30% | Long | EC | |
| ORIC Pharmaceuticals Inc | ORIC | 57,977 | $489,906 | 0.28% | Long | EC | |
| SELLAS Life Sciences Group Inc | SLS | 40,702 | $378,936 | 0.22% | Long | EC |